Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is ...

Vertical Aerospace • EVTL-NYSE Buy • $3.39 on March 12 by Canaccord Genuity We are maintaining our Buy rating on shares of ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where ...

LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST] ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Labcorp has reached an agreement to acquire BioReference Health's oncology diagnostic testing assets for up to $225 million upon closure of the transaction. The deal is expected to close in the ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...